批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2018/12/18 |
SUPPL-24(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/11/05 |
SUPPL-22(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2014/10/16 |
SUPPL-20(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2014/10/16 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2014/09/18 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/07/31 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2014/03/17 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2013/06/14 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2013/05/14 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/01/25 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2010/07/21 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2008/08/12 |
SUPPL-7(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2007/03/19 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2007/03/19 |
SUPPL-2(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/07/05 |
ORIG-1(原始申请) |
Approval |
Type 5 - New Formulation or New Manufacturer |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:MEGESTROL ACETATE 剂型/给药途径:SUSPENSION;ORAL 规格:125MG/ML 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021778 |
001 |
NDA |
MEGACE ES |
MEGESTROL ACETATE |
SUSPENSION;ORAL |
125MG/ML |
Prescription |
Yes |
Yes |
AB |
2005/07/05
|
ENDO OPERATIONS |
203139 |
001 |
ANDA |
MEGESTROL ACETATE |
MEGESTROL ACETATE |
SUSPENSION;ORAL |
125MG/ML |
Prescription |
No |
No |
AB |
2014/08/27
|
TWI PHARMS |
204688 |
001 |
ANDA |
MEGESTROL ACETATE |
MEGESTROL ACETATE |
SUSPENSION;ORAL |
125MG/ML |
Discontinued |
No |
No |
AB |
2017/12/01
|
CHARTWELL |